SCHEMBL14051095

SCHEMBL14051095

Bc1cnn2c(NCc3cccnc3)cc(C3CCCN(C(=O)c4c[nH]c5ccccc45)C3)nc12

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 7/20 0.50
▸ CHEK1 O14757 1/20 0.45
▸ VNN1 O95497 3/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ CDK2 P24941 3/20 0.40
▸ GABRA1 P14867 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA3 P34903 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ GABRB2 P47870 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ CCNE1 P24864 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13288627 0.92 GSK3B (0.52) GSK3BCHEK1VNN1CDK2HTT
SCHEMBL13119170 0.92 GSK3B (0.62) GSK3BCDK2CCNE1
SCHEMBL12954328 0.88 GSK3B (0.47) GSK3BCHEK1VNN1CDK2CCNE1
SCHEMBL12954085 0.86 GSK3B (0.51) GSK3BCHEK1VNN1CDK2CCNE1
SCHEMBL14301565 0.86 GSK3B (0.53) GSK3BCHEK1VNN1CDK2CCNE1
SCHEMBL14307159 0.85 GSK3B (0.52) GSK3BCHEK1VNN1CDK2CCNE1
SCHEMBL13118903 0.84 GSK3B (0.65) GSK3BCDK2CCNE1
SCHEMBL13304610 0.84 GSK3B (0.59) GSK3BCHEK1VNN1CDK2CCNE1
SCHEMBL13304611 0.84 GSK3B (0.59) GSK3BCHEK1VNN1CDK2CCNE1
SCHEMBL13305284 0.84 GSK3B (0.59) GSK3BCHEK1VNN1CDK2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130569-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 — — WO disclosed
Send feedback